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Background
Randomised controlled trials (RCTs) of monitoring
regimes present unique challenges. Trials of monitoring
evaluate a strategy, “a planned and organised system of
repeated assessments and subsequent decisions about
additional interventions, such as starting, stopping or
modifying treatment” [1] all of which should be speci-
fied in advance, and ideally supported by previous
research. The complexity of the intervention and conse-
quent potential for “interactions between tests, repeated
tests, test results and the decisions based on these
results” [1] also necessitates large sample sizes in order
to detect an effect on important patient outcomes.
Objective
To gain an insight into the extent to which monitoring
schedules evaluated in RCTs have been informed by
prior research and to highlight potential issues for
design and analysis of future trials.
Methods
A review of available RCTs of monitoring regimes
intended to allow earlier intervention in people with, or
at high risk of, a condition that is likely to recur or pro-
gress was conducted. An electronic search of the CEN-
TRAL database was carried out using the keywords
(monitor* or serial* or surveill*) in the title or the same
keywords in the abstract combined with (biomarker* or
marker* or test* or examination* or measure*). RCTs
comparing at least one formal monitoring strategy to no
formal monitoring, to an alternative monitoring strategy,
or to immediate treatment were included. Trials of
monitoring where the main purpose was treatment titra-
tion, improvement in adherence to a treatment regimen,
or evaluating ways of delivering monitoring were
excluded. One author conducted the searches, screened
the search results for relevant studies and carried out
the data extraction. A narrative synthesis will be
performed.
Results
Results will be presented for over 20 RCTs. In addition
to information on trial quality, data will be presented on
the extent to which the components of the monitoring
schedule (testing frequency, threshold for intervention
and actions consequent to crossing that threshold) have
been specified. The MRC framework for evaluating
complex interventions will be used to help inform the
extraction of this information [2]. A further focus will
be on the types of outcomes assessed by the trials and
reporting of sample size calculations.
Conclusions
The review’s results will be used to inform guidance
regarding the future evaluation of monitoring regimes.
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